As billions of people in the Global South continue to confront Covid-19 unprotected because they cannot access vaccines, a recent announcement regarding a new, potentially effective therapy offered a glimmer of hope.

McGill University, in conjunction with Universities Allied for Essential Medicines (UAEM), has committed to increasing access to life-saving medicines by adopting Global Access Licensing Principles. McGill is the third Canadian university to adopt the principles, demonstrating a dedication to ensure that any research and university-developed technologies created on McGill’s campus with potential for further development into a drug, vaccine, or medical diagnostic are made affordable to all.